The European Medicines Agency (EMA) said the benefits of the AstraZeneca coronavirus vaccine “outweigh the possible risks”.Emer Cooke, EMA executive director, told a press briefing: “The committee has come to a clear scientific conclusion.“This is a safe and effective vaccine.
Its benefits in protecting people from Covid-19, with the associated risks of death and hospitalisation, outweigh the possible risks.